Want to see HK:8307 full AI Analyst Report?
Medicskin Holdings Ltd. (8307) Ratios
Medicskin Holdings Ltd. Ratios
HK:8307's free cash flow for Q3 2025 was $3.27M. For the 2025 fiscal year, HK:8307's free cash flow was decreased by $-174.00K and operating cash flow was $3.44M. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.86 | 0.86 | 0.93 | 0.91 | 1.01 |
| Quick Ratio | 0.77 | 0.77 | 0.80 | 0.75 | 0.92 |
| Cash Ratio | 0.28 | 0.40 | 0.22 | 0.17 | 0.47 |
| Solvency Ratio | 0.18 | 0.11 | 0.20 | 0.16 | 0.32 |
| Operating Cash Flow Ratio | 0.14 | 0.21 | 0.33 | 0.11 | 0.14 |
| Short-Term Operating Cash Flow Coverage | 0.41 | 1.01 | 1.83 | 0.48 | 0.64 |
| Net Current Asset Value | $ -10.83M | $ -16.10M | $ -2.83M | $ -8.50M | $ -12.40M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.40 | 0.14 | 0.26 | 0.33 |
| Debt-to-Equity Ratio | 3.36 | 5.43 | 0.53 | 0.82 | 1.07 |
| Debt-to-Capital Ratio | 0.77 | 0.84 | 0.34 | 0.45 | 0.52 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 9.77 | 13.69 | 3.66 | 3.20 | 3.25 |
| Debt Service Coverage Ratio | 0.50 | 0.66 | 1.08 | 0.87 | 2.00 |
| Interest Coverage Ratio | 0.35 | 6.22 | 10.56 | -4.37 | 9.19 |
| Debt to Market Cap | 0.24 | 0.12 | 0.10 | 0.07 | 0.08 |
| Interest Debt Per Share | 0.05 | 0.06 | 0.02 | 0.03 | 0.05 |
| Net Debt to EBITDA | 0.81 | 0.87 | -0.17 | 1.08 | 0.31 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.61% | 50.71% | 78.96% | 80.54% | 85.74% |
| EBIT Margin | 0.66% | -6.15% | -5.24% | -6.42% | 9.80% |
| EBITDA Margin | 15.62% | 13.94% | 13.58% | 14.06% | 29.60% |
| Operating Profit Margin | 0.66% | 9.50% | 10.77% | -7.48% | 7.40% |
| Pretax Profit Margin | 1.93% | -7.68% | -6.26% | -8.13% | 9.00% |
| Net Profit Margin | 1.96% | -7.49% | -6.11% | -7.77% | 7.98% |
| Continuous Operations Profit Margin | 1.96% | -7.50% | -6.22% | -7.88% | 8.43% |
| Net Income Per EBT | 101.52% | 97.52% | 97.57% | 95.52% | 88.71% |
| EBT Per EBIT | 293.63% | -80.84% | -58.12% | 108.75% | 121.52% |
| Return on Assets (ROA) | 1.83% | -5.88% | -7.61% | -7.63% | 6.92% |
| Return on Equity (ROE) | 17.91% | -80.50% | -27.84% | -24.44% | 22.50% |
| Return on Capital Employed (ROCE) | 3.09% | 30.32% | 64.60% | -19.93% | 13.57% |
| Return on Invested Capital (ROIC) | 1.30% | 14.80% | 26.91% | -10.83% | 8.47% |
| Return on Tangible Assets | 1.83% | -5.88% | -7.61% | -7.63% | 6.92% |
| Earnings Yield | 1.57% | -4.60% | -5.30% | -3.50% | 4.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 107.09 | 20.16 | 49.74 | 53.64 | 167.17 |
| Payables Turnover | 38.95 | 28.99 | 27.16 | 35.03 | 28.50 |
| Inventory Turnover | 8.38 | 6.12 | 7.84 | 1.83 | 2.61 |
| Fixed Asset Turnover | 3.82 | 2.51 | 4.85 | 2.66 | 2.04 |
| Asset Turnover | 0.94 | 0.79 | 1.25 | 0.98 | 0.87 |
| Working Capital Turnover Ratio | -7.93 | -10.92 | -21.37 | -38.76 | 12.44 |
| Cash Conversion Cycle | 37.57 | 65.13 | 40.48 | 195.79 | 129.02 |
| Days of Sales Outstanding | 3.41 | 18.10 | 7.34 | 6.80 | 2.18 |
| Days of Inventory Outstanding | 43.53 | 59.62 | 46.58 | 199.41 | 139.65 |
| Days of Payables Outstanding | 9.37 | 12.59 | 13.44 | 10.42 | 12.81 |
| Operating Cycle | 46.94 | 77.72 | 53.92 | 206.21 | 141.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.01 | 0.02 | 0.03 | 0.01 | 0.01 |
| Free Cash Flow Per Share | 0.01 | 0.02 | 0.02 | 0.00 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | 4.58 | 10.81 | 7.53 | 1.41 | 0.36 |
| Capital Expenditure Coverage Ratio | 4.58 | 10.81 | 7.53 | 1.41 | 2.19 |
| Operating Cash Flow Coverage Ratio | 0.33 | 0.40 | 1.83 | 0.27 | 0.23 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.20 | 0.21 | 0.07 | 0.09 |
| Free Cash Flow Yield | 7.63% | 11.29% | 15.85% | 0.94% | 2.69% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 62.50 | -21.76 | -18.87 | -28.60 | 22.05 |
| Price-to-Sales (P/S) Ratio | 1.24 | 1.63 | 1.15 | 2.22 | 1.76 |
| Price-to-Book (P/B) Ratio | 11.39 | 17.50 | 5.25 | 6.99 | 4.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.10 | 8.86 | 6.31 | 106.94 | 37.14 |
| Price-to-Operating Cash Flow Ratio | 10.24 | 8.04 | 5.47 | 31.17 | 20.14 |
| Price-to-Earnings Growth (PEG) Ratio | -0.49 | -2.09 | 1.40 | 0.15 | 0.07 |
| Enterprise Value Multiple | 8.76 | 12.54 | 8.32 | 16.89 | 6.25 |
| Enterprise Value | 65.55M | 78.85M | 56.36M | 108.09M | 91.00M |
| EV to EBITDA | 8.76 | 12.54 | 8.32 | 16.89 | 6.25 |
| EV to Sales | 1.37 | 1.75 | 1.13 | 2.37 | 1.85 |
| EV to Free Cash Flow | 14.43 | 9.51 | 6.18 | 114.26 | 39.07 |
| EV to Operating Cash Flow | 11.28 | 8.63 | 5.36 | 33.30 | 21.19 |
| Tangible Book Value Per Share | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.03 | 0.04 | 0.04 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | 0.02 | 0.01 | 0.03 | 0.06 |
| Revenue Per Share | 0.12 | 0.11 | 0.13 | 0.11 | 0.12 |
| Net Income Per Share | 0.00 | -0.01 | -0.01 | -0.01 | 0.01 |
| Tax Burden | 1.02 | 0.98 | 0.98 | 0.96 | 0.89 |
| Interest Burden | 2.94 | 1.25 | 1.19 | 1.27 | 0.92 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.36 | 0.39 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 6.21 | -2.64 | -3.45 | -1.07 | 0.97 |
Currency in HKD
